Sort
21,281 grants matching “influenza”
Pan-vaccine Analysis to Test the Impact of Cytomegalovirus on Vaccine Efficacy
$201,875Zicheng Hu · University Of California, San Francisco · UH2 · FY2021 · AI
Protecting Patients with Glomerular Disease from Vaccine-Preventable Infections
$201,840Dorey Glenn · Univ Of North Carolina Chapel Hill · K23 · FY2022 · AI
Midcareer Investigator Award in Patient-Oriented Research (K24)
$201,648Patricia L Hibberd · Massachusetts General Hospital · K24 · FY2014 · AT
Midcareer Investigator Award in Patient-Oriented Research (K24)
$201,648Patricia L Hibberd · Massachusetts General Hospital · K24 · FY2011 · AT
Midcareer Investigator Award in Patient-Oriented Research (K24)
$201,648Patricia L Hibberd · Massachusetts General Hospital · K24 · FY2012 · AT
Midcareer Investigator Award in Patient-Oriented Research (K24)
$201,648Patricia L Hibberd · Massachusetts General Hospital · K24 · FY2015 · AT
Exploring alternate targets for inhibition of virus infection by PPI disruption
$201,575Michael A Calderwood · Dana-Farber Cancer Inst · R21 · FY2021 · AI
Computationally designed anchor scaffolds for elicitation of broadly neutralizing influenza antibodies
$201,480Jarrod Mousa · Florida State University · R21 · FY2023 · AI
Protecting Patients with Glomerular Disease from Vaccine-Preventable Infections
$201,424Dorey Glenn · Univ Of North Carolina Chapel Hill · K23 · FY2023 · AI
Lentiviral Vector Vaccine for HIV-1
$201,420Thomas D Norton · New York University School Of Medicine · K08 · FY2017 · AI
HIV Infection, Placental Inflammation, and Early Childhood Outcomes in HIV-exposed, Uninfected Infants in Uganda
$201,298Lisa M Bebell · Massachusetts General Hospital · K23 · FY2019 · AI
A pilot study for development of inhibitors of influenza virus
$201,278Ming Luo · Univ Of North Carolina Chapel Hill · U54 · FY2008 · AI
Structural Dynamics of Rotavirus Transcription
$201,250Sarah Marie McDonald Esstman · Virginia Polytechnic Inst And St Univ · R21 · FY2014 · AI
Structural Dynamics of Rotavirus Transcription
$201,250Sarah Marie McDonald Esstman · Virginia Polytechnic Inst And St Univ · R21 · FY2015 · AI
Aloperine derivatives as novel anti-influenza agents
$201,250Li Huang · Duke University · R21 · FY2020 · AI
Allosteric regulation of a viral RNA-dependent RNA polymerase
$201,250Sarah Marie McDonald Esstman · Virginia Polytechnic Inst And St Univ · R21 · FY2016 · AI
Infectious Influence: Using fate mapping to determine the impact of viral infection sites on Alzheimer's disease initiation
$201,250E. Ashley Moseman · Duke University · R21 · FY2022 · AG
STRENGTHENING INFLUENZA SURVEILLANCE AND PANDEMIC PREPAREDNESS
$201,222Nurbolot Usenbaev · Ministry Of Health / Kyrgyz Republic · U51 · FY2014 · IP
Monoclonal Antibody Core
$201,170Patrick Christopher Wilson · Icahn School Of Medicine At Mount Sinai · U19 · FY2015 · AI
Monoclonal Antibody Core
$201,170Patrick Christopher Wilson · Icahn School Of Medicine At Mount Sinai · U19 · FY2017 · AI
Monoclonal Antibody Core
$201,170Patrick Christopher Wilson · Icahn School Of Medicine At Mount Sinai · U19 · FY2018 · AI
TRANSGENIC ANIMAL MODEL DEVELOPMENT--PKR PROTEIN KINASE
$201,148University Of Washington · R24 · FY2001 · RR
Increasing HPV Vaccination Rates through Virtual Immersive Communication Training on Recommending Immunizations: An Efficacy Study of VICTORI
$201,071Francis Real · Cincinnati Childrens Hosp Med Ctr · R21 · FY2020 · CA
Laser-based powder vaccine delivery for improved newborn immunization
$200,972Xinyuan Chen · Massachusetts General Hospital · R21 · FY2013 · AI
CORE D: HUMAN MAB CORE
$200,914Kenneth Michael Smith · Oklahoma Medical Research Foundation · P30 · FY2011 · RR